Science Explorer Interactive view Map
Nonprofit · Bogotá · ??

Asociación Colombiana de Hematología y Oncología

acho.com.coROR OpenAlex
Research works
33
▲ 105% vs 2013–17
Citations
31
1.0 per fractional work
Top-10% rate
4.9%
record average 16.5%
Open access
93%
world 28%

Not ranked overall: Asociación Colombiana de Hematología y Oncología is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.33× its world share, 0 worksBiochemistry, Geneti…Environmental Science: 0.54× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.40× its world share, 0 worksHealth ProfessionsMedicine: 4.13× its world share, 2 worksMedicineDecision Sciences: 9.01× its world share, 0 worksDecision SciencesSocial Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Decision Sciences, 9.0×. Every wedge is a field page.

Which keywords describe research at Asociación Colombiana de Hematología y Oncología?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Prognostic Factors, Healthcare Access, Breast Cancer, Public Health, Minimal Residual Disease, Staging System and Metastatic Breast Cancer.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Chemotherapy3▲ 13×13 topics
  2. Healthcare Access3▲ 45×3 topics
  3. Prognostic Factors3▲ 19×7 topics
  4. Public Health3▲ 6.1×6 topics
  5. Breast Cancer3▲ 29×5 topics
  6. Minimal Residual Disease2▲ 110×2 topics
  7. Quality of Life2▲ 4.9×6 topics
  8. Staging System2▲ 96×2 topics
  9. Immunotherapy2▲ 8.7×5 topics
  10. Metastatic Breast Cancer2▲ 89×2 topics
  11. Tumor Microenvironment2▲ 16×5 topics
  12. Diagnosis Criteria2▲ 182×1 topic
  13. International Myeloma Working Group2▲ 182×1 topic
  14. Clinical Trials2▲ 7.8×4 topics
  15. Healthcare Policy2▲ 66×2 topics
  16. Lymphoma2▲ 32×2 topics
  17. Mutation2▲ 29×2 topics
  18. PET Imaging2▲ 21×3 topics
  19. Rituximab2▲ 29×2 topics
  20. BCR-ABL1▲ 158×1 topic
  21. CDK4/6 Inhibitors1▲ 268×1 topic
  22. Environmental Management1▲ 18×1 topic
  23. Imatinib1▲ 158×1 topic
  24. Palbociclib1▲ 268×1 topic
  25. Water Quality1▲ 10×1 topic
  26. Epidemiology1◆ 1.02×8 topics
  27. Gene Expression Profiling1▲ 41×2 topics
  28. Health-related Quality of Life1▲ 18×2 topics
  29. Metastasis1▲ 12×4 topics
  30. Molecular Profiling1▲ 33×2 topics
  31. Risk Factors1▲ 3.8×5 topics
  32. Targeted Therapy1▲ 18×3 topics
  33. Cancer1▲ 2.6×5 topics
  34. Cervical Cancer1▲ 34×2 topics
  35. Cancer Immunotherapy1▲ 23×2 topics
  36. Classification1▲ 8.8×2 topics

Which research topics does Asociación Colombiana de Hematología y Oncología publish most on?

By volume in 2022–2025: scientometrics and bibliometrics research, HIV/AIDS oral health manifestations, Health and Medical Research Impacts and Acute Myeloid Leukemia Research.

scientometrics and bibli…0scientometrics and bibliometrics research: 0 fractional worksHIV/AIDS oral health man…0HIV/AIDS oral health manifestations: 0 fractional worksHealth and Medical Resea…0Health and Medical Research Impacts: 0 fractional worksAcute Myeloid Leukemia R…0Acute Myeloid Leukemia Research: 0 fractional worksInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 0 fractional worksRespiratory viral infections research: 0 fractional worksCOVID-19 and healthcare …0COVID-19 and healthcare impacts: 0 fractional worksEosinophilic Disorders and Syndromes: 0 fractional worksRetinoids in leukemia and cellular processes: 0 fractional worksMultiple Myeloma Research and Treatments: 0 fractional works
Statistics, Probability and UncertaintyPublic Health, Environmental and Occupational HealthHematologyPulmonary and Respiratory Medicine4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 scientometrics and bibliometrics research Statistics, Probability and Uncertainty 0 works
  2. 2 HIV/AIDS oral health manifestations Public Health, Environmental and Occupational Health 0 works
  3. 3 Health and Medical Research Impacts Public Health, Environmental and Occupational Health 0 works
  4. 4 Acute Myeloid Leukemia Research Hematology 0 works
  5. 5 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
  6. 6 Respiratory viral infections research Epidemiology 0 works
  7. 7 COVID-19 and healthcare impacts Oncology 0 works
  8. 8 Eosinophilic Disorders and Syndromes Rheumatology 0 works
  9. 9 Retinoids in leukemia and cellular processes Molecular Biology 0 works
  10. 10 Multiple Myeloma Research and Treatments Hematology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available92.8%not open7.2%

World: 28% of research is openly available.

with international co-authors8.2%domestic only91.8%

World: 19% is written across borders.

How has Asociación Colombiana de Hematología y Oncología's research output changed?

Output in 2018–2022 was 105% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Bogotá

All research institutions in Bogotá

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.